A phase IIa study to evaluate the safety, pharmacodynamics and pharmacokinetics of TGN255 in stable haemodialysis patients

被引：0

作者：

Combe, Sophie

DSouza, Richard

Mysliwiec, Michal

Padmanabhan, Neal

Thomas, Mark

Villa, Giuseppe

Will, Eric

Patrick, Guy

Kennedy, Anthony

机构：

[1] Trigen, London, England

[2] Royal Devon & Exeter Hosp, Exeter Kidney Unit, Exeter EX2 5DW, Devon, England

[3] Bialystok Med Univ, Bialystok, Poland

[4] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland

[5] Birmingham Heartlands Hosp, Glaxo Renal Unit, Birmingham B9 5ST, W Midlands, England

[6] Fdn S Maugeri, Pavia, Italy

[7] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England

[8] Premier Res, Crowthorne, Berks, England

来源：

关键词：

D O I：

暂无

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：215 / 216

页数：2